MAPT and Alzheimer disease: With respect to classical AD CSF biomarkers, AD patients showed the characteristic profiles characterized by low levels of Aß42 and high levels of t- and p-tau, whereas the CNS group had high levels of Aß42 and low levels of t- and p- tau.